Superbranche
Venture Round in 2025
Superbranche is a biotechnology company focused on the early detection and treatment of metastases through innovative nanotechnological solutions. The company develops therapeutic and diagnostic applications aimed at improving accessibility and enabling the early identification of tumors. Utilizing proprietary technology, Superbranche's platform delivers targeted diagnostic tools and image-guided therapy nanomaterials to clinical settings, enhancing the effectiveness of cancer treatment by allowing for timely interventions. Through its advancements in nanotechnology, Superbranche seeks to transform the landscape of cancer care by prioritizing early detection and personalized treatment strategies.
Keey Aerogel
Series A in 2025
Keey Aerogel is a specialized manufacturer of silica aerogel, utilizing a closed-loop process that recycles construction waste, carbon dioxide, and ethanol. The company focuses on the valorization of silica-containing materials from construction and demolition activities, aiming to create energy-efficient building solutions and materials for various industrial applications. By producing this innovative nanoporous material, Keey Aerogel provides effective thermal insulation in ambient conditions, contributing to sustainability in construction and refurbishment projects.
Cixten is a technology company that specializes in recycling low-temperature waste heat from various industrial processes. It achieves this by harnessing the unique properties of supercritical CO2, converting the waste heat into usable energy forms such as electricity, compressed gas, or thermal upgrades, as per the specific requirements of its clients. This process not only helps businesses reduce their reliance on traditional energy sources but also contributes to a more sustainable and efficient use of energy.
Sirfull Technology
Venture Round in 2024
Sirfull Technology is a software company based in Schiltigheim, France, specializing in welding quality and equipment life cycle management. It develops cloud-based software solutions, including VDB, which manages welding quality control and technical documentation, and IRM, an equipment inspection platform that integrates inspection, monitoring, and risk management for industrial equipment. These tools are designed to optimize business processes by centralizing information on a collaborative platform. Sirfull Technology serves a range of industries, including oil and gas, chemical, pharmaceutical, and energy sectors. In addition to its software offerings, the company provides technical outsourcing and integration services, with products available as Software-as-a-Service or for installation on PC or server systems.
RDS is a healthcare technology startup focused on remote patient monitoring solutions. Its flagship product, MultiSense®, is a high-precision, multi-parametric monitoring system that enables healthcare professionals to continuously track patients' physiological parameters in both hospital and home settings. This innovative, multi-patented device combines a wearable monitor with a cloud platform, transforming collected data into actionable clinical insights. RDS targets hospitals, particularly surgical departments, seeking to enhance patient care and reduce hospital stays through early discharge and continuous monitoring, ultimately contributing to significant healthcare savings. The MultiSense® solution is CE marked (MDR) and is available in several European countries. RDS operates on a recurring revenue model through a "fee for service" approach, offering training and support to healthcare professionals for effective implementation. The company's commitment to improving patient pathways has been recognized with multiple awards and validation from completed clinical investigations, supported by a skilled international team with extensive expertise in healthcare and medical devices.
Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.
Braintale
Venture Round in 2023
Braintale is a Paris-based company founded in 2018 that specializes in developing and distributing innovative diagnostic and prognostic tools specifically for brain-injured patients. The company's digital medical care platform is designed for hospitals to effectively analyze MRI reports, providing accessible solutions that meet the needs of healthcare professionals and patients alike. Braintale’s products are grounded in over 15 years of clinical development, focusing on predicting patient outcomes, particularly for those in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. By facilitating easier diagnoses, Braintale aims to enhance patient care in critical settings, ultimately improving the prognosis for individuals with severe brain injuries.
Odimma is a biotech company specializing in precision medicine aimed at developing personalized cancer immunotherapy solutions. The company has created an innovative immunotherapy drug that harnesses a unique platform, integrating three specific immune components designed to work together with the patient's immune system. When administered, this approach aims to induce and enhance immune responses, providing patients with the potential to eliminate tumors while minimizing adverse side effects. Through its focus on personalized treatment strategies, Odimma seeks to improve outcomes for cancer patients by tailoring therapies to individual needs.
Miraxess
Venture Round in 2023
Miraxess is a technology company that specializes in transforming smartphones into functional laptops through its innovative product, the Mirabook. This device acts as a laptop extension, allowing users to connect their smartphones and harness the full capabilities of their mobile devices. As smartphones increasingly serve as the primary tools for personal and professional tasks, Miraxess provides a solution that enhances productivity and comfort for both work and entertainment. By enabling mobile convergence, the company addresses the evolving needs of consumers who seek to maximize the utility of their smartphones in a laptop format.